G. Hudson

发表

British National Lymphoma Investigation: pilot studies of neoadjuvant chemotherapy in clinical stage Ia and IIa Hodgkin's disease.

M. Williams, P. Smith, A. M. Moody, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

Why don't cancer patients get entered into clinical trials? Experience of the Sheffield Lymphoma Group's collaboration in British National Lymphoma Investigation studies

M. Aitken, B. Hancock, G. Hudson, 1997, BMJ.

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

K. Maclennan, D. Linch, P. Hoskin, 2003, The Lancet.

Factors affecting relapse following chemotherapy for Hodgkin's disease.

J. Yarnold, A. Jelliffe, G. Hudson, 1982, Clinical radiology.

Non-Hodgkin’s lymphoma arising in patients treated for Hodgkin’s disease in the BNLI: A 20-year experience

K. Maclennan, G. Hudson, M. Bennett, 1991 .

Riskofsecond primary cancerafter Hodgkin's disease inpatients inthe British National LymphomaInvestigation: relationships tohostfactors, histology andstageofHodgkin's disease, andsplenectomy

K. Maclennan, A. Swerdlow, A. Douglas, 1993 .

A Randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma

K. Maclennan, W. Gregory, D. Cunningham, 2000 .

Variation in mantle technique: implications for establishing priorities for quality assurance in clinical trials.

D. Sebag‐Montefiore, J. Young, G. Hanks, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Clinical and Prognostic Relevance of Histopathologic Classification in Hodgkin’s Disease

K. Maclennan, G. Hudson, M. Bennett, 1989 .

Analysis of grade 1 Hodgkin's disease (Report no 6).

G. Hudson, M. Bennett, A. Tu, 1981, Clinical radiology.

The pretreatment peripheral blood lymphocyte count in 1100 patients with Hodgkin's disease: the prognostic significance and the relationship to the presence of systemic symptoms.

K. Maclennan, J. Haybittle, A. Jelliffe, 1981, Clinical oncology.

REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEX

K. Maclennan, J. Haybittle, F. Hayhoe, 1985, The Lancet.

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

D. Winfield, D. Linch, R. Chopra, 1993, The Lancet.

randomized trial of PAdriaCEBO versus PMitCEBO patients older than 60 with high-grade lymphoma: results of a BNLI Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for

K. Maclennan, W. Gregory, P. Hoskin, 2008 .

Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.

K. Maclennan, W. Gregory, P. Hoskin, 2001, Blood.

ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial

K. Maclennan, W. Gregory, D. Linch, 2001, British Journal of Cancer.

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.

K. Maclennan, A. Swerdlow, A. Douglas, 1992, BMJ.

The evolution of the British National Lymphoma Investigation (Report no 5).

A. Jelliffe, G. Hudson, 1981, Clinical radiology.

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.

T. Lister, A. Horwich, R. Gupta, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-Hodgkin's lymphoma of the testis.

A. Crellin, G. Hudson, M. Bennett, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML

W. Gregory, P. Hoskin, D. Winfield, 1999, British Journal of Cancer.

Localised grade 2 non-Hodgkin's lymphoma: results of treatment with radiotherapy (BNLI Report No. 24).

K. Maclennan, D. Lamb, M. Easterling, 1984, Clinical radiology.

The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital.

R. Laing, K. Maclennan, P. Hoskin, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Risk o f S econd M alignancy A fter H odgkin's D isease i n a Collaborative B ritish C ohort: T he R elation t o A ge a t T reatment

A. Horwich, D. Cunningham, G. Hudson, 2000 .

A British national lymphoma investigation randomised trial of single agent chlorambucil plus radiotherapyversus radiotherapy alone in low grade, localised non-hodgkins Lymphoma

A. Newland, S. Kelsey, A. Jelliffe, 1994, Medical oncology.

Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study.

D C Linch, K. Maclennan, D. Cunningham, 1996, Blood.

Hodgkin's disease in childhood: the British National Lymphoma Investigation experience (BNLI Report No 27).

K. Maclennan, A. Jelliffe, G. Hudson, 1987, Clinical radiology.

Patterns of relapse following radiotherapy for Hodgkin's disease.

J. Yarnold, A. Jelliffe, G. Hudson, 1982, Clinical radiology.

patterns of Relapse ttodgkin's Disease following Radiotherapy for

J. Yarnold, A. Jelliffe, G. Hudson, 1982 .

The response to treatment of nodular sclerosing Hodgkin's disease with extranodal involvement.

K. Maclennan, A. Jelliffe, G. Vaughan Hudson, 1982, Clinical radiology.

Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.

M. Williams, T. Lister, A. Horwich, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.